These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26834740)

  • 1. Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
    Vandenberk L; Belmans J; Van Woensel M; Riva M; Van Gool SW
    Front Immunol; 2015; 6():663. PubMed ID: 26834740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inducers of immunogenic cell death for tumor immunotherapy.
    Li X
    Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell vaccination in melanoma patients: From promising results to future perspectives.
    Boudewijns S; Bloemendal M; Gerritsen WR; de Vries IJ; Schreibelt G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2523-2528. PubMed ID: 27322496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
    Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
    Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
    Laureano RS; Sprooten J; Vanmeerbeerk I; Borras DM; Govaerts J; Naulaerts S; Berneman ZN; Beuselinck B; Bol KF; Borst J; Coosemans A; Datsi A; Fučíková J; Kinget L; Neyns B; Schreibelt G; Smits E; Sorg RV; Spisek R; Thielemans K; Tuyaerts S; De Vleeschouwer S; de Vries IJM; Xiao Y; Garg AD
    Oncoimmunology; 2022; 11(1):2096363. PubMed ID: 35800158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer.
    Kim HS; Choo YS; Koo T; Bang S; Oh TY; Wen J; Song SY
    Immunol Lett; 2006 Mar; 103(2):142-8. PubMed ID: 16313973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferons and dendritic cells in cancer immunotherapy.
    Sprooten J; Agostinis P; Garg AD
    Int Rev Cell Mol Biol; 2019; 348():217-262. PubMed ID: 31810554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components.
    Lin TJ; Lin HT; Chang WT; Mitapalli S P; Hsiao PW; Yin SY; Yang NS
    Mol Cancer; 2015 Sep; 14():174. PubMed ID: 26403780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma.
    Ji J; Fan Z; Zhou F; Wang X; Shi L; Zhang H; Wang P; Yang D; Zhang L; Chen WR; Wang X
    Oncotarget; 2015 Jul; 6(19):17135-46. PubMed ID: 25915530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity.
    Lamberti MJ; Nigro A; Mentucci FM; Rumie Vittar NB; Casolaro V; Dal Col J
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32178288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.
    Adkins I; Fucikova J; Garg AD; Agostinis P; Špíšek R
    Oncoimmunology; 2014 Dec; 3(12):e968434. PubMed ID: 25964865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
    Dobrovolskienė N; Pašukonienė V; Darinskas A; Kraśko JA; Žilionytė K; Mlynska A; Gudlevičienė Ž; Mišeikytė-Kaubrienė E; Schijns V; Lubitz W; Kudela P; Strioga M
    Vaccine; 2018 Jul; 36(29):4171-4180. PubMed ID: 29895501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.
    Truxova I; Hensler M; Skapa P; Halaska MJ; Laco J; Ryska A; Spisek R; Fucikova J
    Int Rev Cell Mol Biol; 2017; 330():115-156. PubMed ID: 28215530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
    Salem ML
    Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation dendritic cell-based vaccines for leukemia patients.
    Hoffmann JM; Schmitt M; Ni M; Schmitt A
    Immunotherapy; 2017 Jan; 9(2):173-181. PubMed ID: 28128712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.
    Garg AD; Coulie PG; Van den Eynde BJ; Agostinis P
    Trends Immunol; 2017 Aug; 38(8):577-593. PubMed ID: 28610825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.
    Hargadon KM
    Front Immunol; 2017; 8():1594. PubMed ID: 29209327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.